AIP Form 144: 50K Share Insider Sale Filed for June 27, 2025

Rhea-AI Filing Summary

Arteris, Inc. (symbol AIP) has filed a Form 144 indicating the planned disposition of 50,000 common shares through Morgan Stanley Smith Barney on or about 27 June 2025. At the most recent market price implied in the filing, the transaction is valued at approximately $479,000, representing roughly 0.12 % of the company’s 41,977,728 shares outstanding.

The person on whose behalf the sale will be made is listed as K. Charles Janac. Rule 144 requires disclosure of aggregate sales by the same holder; accordingly, the filing also details prior 10b5-1-related sales over the last three months totaling 19,603 shares for gross proceeds of $137,144.51. When combined with the proposed sale, the holder will have sold 69,603 shares during the period.

Form 144 further confirms that the seller attests to possessing no material non-public adverse information and, if operating under a 10b5-1 plan, has disclosed the plan adoption date. No relationship to the issuer or additional remarks were provided in the filing.

While the absolute number of shares is modest in relation to the float, continued insider dispositions may be monitored by investors as a potential sentiment signal.

Positive

• None.

Negative

• Continued insider selling: Proposed 50,000-share sale adds to 19,603 shares already sold in the last three months, which some investors may interpret as a bearish sentiment signal.

Insights

Securities Analyst

TL;DR: Insider plans to sell 50k AIP shares (~$479k); cumulative recent sales 69.6k shares—small vs. float but worth monitoring.

The filing is a routine Form 144, yet it shows an ongoing pattern of sales by the same holder. The proposed 50,000-share sale is only 0.12 % of outstanding stock, so immediate price impact should be minimal. Nevertheless, repeated sales within a three-month window (totaling 69,603 shares) may suggest portfolio diversification or personal liquidity needs. The absence of contextual information—such as executive role, performance metrics, or strategy updates—limits conclusions on motive. Investors typically view sustained insider selling as a mild negative unless offset by corporate fundamentals or share-buyback activity.

Corporate Governance Expert

TL;DR: Routine Rule 144 notice; sale size immaterial to float, signals limited governance concern.

From a governance stance, the disclosure satisfies SEC requirements: broker identified, sale date specified, historical 10b5-1 trades provided, and representation of no undisclosed MNPI. Lack of relationship details (director, officer, affiliate) marginally reduces transparency but does not violate Rule 144. The filing does not indicate problematic timing (e.g., immediately before earnings). Overall, the event is administratively neutral; risk of reputational or control change is negligible.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	479000.00	41977728	06/27/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/05/2013	Private Purchase	Issuer			50000	11/05/2013	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	COMMON	06/04/2025	2057	16102.20
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	COMMON	06/02/2025	1246	9598.31
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	COMMON	04/03/2025	9150	60546.01
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	COMMON	04/02/2025	7150	50897.99

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Arteris (AIP) shares are being proposed for sale in this Form 144?

The filing covers 50,000 common shares with an estimated value of $479,000.

What percentage of Arteris’s outstanding shares does the proposed 50,000-share sale represent?

Approximately 0.12 % of the 41,977,728 shares outstanding reported in the filing.

Who is the person for whose account the AIP shares will be sold?

The filing lists K. Charles Janac as the person on whose behalf the securities are to be sold.

Which broker will execute the proposed sale of Arteris shares?

The broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York.

What insider sales of AIP stock occurred in the past three months?

The same holder sold 19,603 shares between 2 April and 4 June 2025 for gross proceeds of $137,144.51.

On what date is the proposed sale of Arteris shares expected to occur?

The approximate sale date disclosed is June 27, 2025.